HEPCLUDEX
BULEVIRTIDE
Listed by Gilead Sciences, Inc.
- Strength
- 8.5 mg/1
- Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Subcutaneous
What it contains
- Bulevirtide Acetate 8.5 mg/1
FDA record
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Subcutaneous |
| Approval route | BLA — biologic licence |
| NDC code | 61958-3104 |
| FDA application | BLA761468 |
| RxNorm concept | 2743611 |
| Package sizes listed | 1 |
| Marketed since | May 2026 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.